Last quarter (Q ), Guided Therapeutics's total revenue was $32.00K, an increase of 966.67% from the same quarter last year. In Q, Guided Therapeutics's net income was $-469.00K. See Guided Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 98.00K	$ 98.00K	$ 13.00K	$ 81.00K	$ 102.00K	$ 36.00K
Cost of Revenue	$ -21.00K	$ 62.00K	$ -81.00K	$ 61.00K	$ -41.00K	$ 70.00K
Gross Profit	$ -39.00K	$ 36.00K	$ -68.00K	$ 20.00K	$ 143.00K	$ -34.00K
Operating Expense	$ 2.00M	$ 3.49M	$ -3.27M	$ -2.38M	$ 1.20M	$ 903.00K
Operating Income	$ -4.90M	$ -3.46M	$ -4.45M	$ -2.36M	$ -1.05M	$ -937.00K
Net Non Operating Interest Income Expense	$ -20.00K	$ -278.00K	$ -325.00K	$ -1.15M	$ -1.06M	$ -1.41M
Other Income Expense	$ -107.00K	$ -240.00K	$ -728.00K	$ -1.44M	$ 1.83M	$ 428.00K
Pretax Income	$ -4.62M	$ -3.49M	$ -4.34M	$ -2.07M	$ -279.00K	$ -1.92M
Tax Provision	-	-	-	-	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	$ 6.00K	-	-	-	-	-
Net Income Common Stockholders	$ -12.65M	$ -3.76M	$ -11.79M	$ -1.71M	$ -401.00K	$ -1.92M
Basic EPS	$ -0.09	$ -0.07	$ -0.15	$ -0.18	$ -0.04	$ -0.58
Diluted EPS	$ -0.09	$ -0.07	$ -0.15	$ -0.18	$ -0.04	$ -0.58
Basic Average Shares	$ 185.56M	$ 51.13M	$ 32.51M	$ 13.38M	$ 10.77M	$ 3.30M
Diluted Average Shares	$ 185.56M	$ 51.13M	$ 32.51M	$ 13.38M	$ 10.77M	$ 3.30M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 1.98M	$ 3.56M	$ -3.35M	$ -2.32M	$ 1.15M	$ 973.00K
Net Income From Continuing And Discontinued Operation	$ -11.92M	$ -3.49M	$ -11.16M	$ -2.07M	$ -279.00K	$ -1.92M
Normalized Income	$ -482.63K	$ -2.93M	-	-	$ -1.84M	$ -2.30M
Interest Expense	-	-	-	-	$ 1.06M	$ 1.41M
EBIT	$ -4.60M	$ -3.21M	$ -3.76M	$ -920.00K	$ 777.00K	$ -509.00K
EBITDA	$ -2.57M	$ -3.00M	$ -3.54M	$ -509.00K	$ 777.00K	$ -488.00K

Currency in USD

Guided Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing